Century Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IPSC and other ETFs, options, and stocks.About IPSC
Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer.
CEOBrent Pfeiffenberger
CEOBrent Pfeiffenberger
Employees150
Employees150
HeadquartersPhiladelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded2018
Founded2018
Employees150
Employees150
IPSC Key Statistics
Market cap49.11M
Market cap49.11M
Price-Earnings ratio-1.79
Price-Earnings ratio-1.79
Dividend yield—
Dividend yield—
Average volume852.67K
Average volume852.67K
High today$0.5989
High today$0.5989
Low today$0.555
Low today$0.555
Open price$0.5916
Open price$0.5916
Volume501.91K
Volume501.91K
52 Week high$1.27
52 Week high$1.27
52 Week low$0.3418
52 Week low$0.3418
Stock Snapshot
With a market cap of 49.11M, Century Therapeutics(IPSC) trades at $0.56. The stock has a price-to-earnings ratio of -1.79.
During the trading session on 2025-12-13, Century Therapeutics(IPSC) shares reached a daily high of $0.60 and a low of $0.56. At a current price of $0.56, the stock is +0.5% higher than the low and still -6.9% under the high.
Trading activity shows a volume of 501.91K, compared to an average daily volume of 852.67K.
The stock's 52-week range extends from a low of $0.34 to a high of $1.27.
The stock's 52-week range extends from a low of $0.34 to a high of $1.27.
People also own
Based on the portfolios of people who own IPSC. This list is generated using Robinhood data, and it’s not a recommendation.